Russell Investments Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-37,900
| Closed | -$7.98K | – | 3668 |
|
2023
Q2 | $7.98K | Hold |
37,900
| – | – | ﹤0.01% | 3013 |
|
2023
Q1 | $6.06K | Hold |
37,900
| – | – | ﹤0.01% | 2935 |
|
2022
Q4 | $21K | Hold |
37,900
| – | – | ﹤0.01% | 2794 |
|
2022
Q3 | $45K | Hold |
37,900
| – | – | ﹤0.01% | 2753 |
|
2022
Q2 | $23K | Hold |
37,900
| – | – | ﹤0.01% | 2789 |
|
2022
Q1 | $43K | Hold |
37,900
| – | – | ﹤0.01% | 2635 |
|
2021
Q4 | $85K | Hold |
37,900
| – | – | ﹤0.01% | 2855 |
|
2021
Q3 | $129K | Hold |
37,900
| – | – | ﹤0.01% | 2848 |
|
2021
Q2 | $113K | Sell |
37,900
-31,635
| -45% | -$94.3K | ﹤0.01% | 3037 |
|
2021
Q1 | $223K | Buy |
69,535
+31,457
| +83% | +$101K | ﹤0.01% | 2791 |
|
2020
Q4 | $79K | Sell |
38,078
-5,331
| -12% | -$11.1K | ﹤0.01% | 2883 |
|
2020
Q3 | $50K | Sell |
43,409
-42
| -0.1% | -$48 | ﹤0.01% | 3078 |
|
2020
Q2 | $39K | Buy |
43,451
+17,051
| +65% | +$15.3K | ﹤0.01% | 3007 |
|
2020
Q1 | $21K | Sell |
26,400
-1,800
| -6% | -$1.43K | ﹤0.01% | 2950 |
|
2019
Q4 | $26K | Sell |
28,200
-100
| -0.4% | -$92 | ﹤0.01% | 3025 |
|
2019
Q3 | $29K | Sell |
28,300
-1,000
| -3% | -$1.03K | ﹤0.01% | 2956 |
|
2019
Q2 | $53K | Buy |
29,300
+6,400
| +28% | +$11.6K | ﹤0.01% | 2726 |
|
2019
Q1 | $43K | Buy |
22,900
+5,700
| +33% | +$10.7K | ﹤0.01% | 2814 |
|
2018
Q4 | $21K | Buy |
+17,200
| New | +$21K | ﹤0.01% | 2861 |
|
2018
Q2 | – | Sell |
-28,000
| Closed | -$59K | – | 2983 |
|
2018
Q1 | $59K | Sell |
28,000
-12,900
| -32% | -$27.2K | ﹤0.01% | 2815 |
|
2017
Q4 | $91K | Sell |
40,900
-1,800
| -4% | -$4.01K | ﹤0.01% | 2794 |
|
2017
Q3 | $57K | Sell |
42,700
-56,400
| -57% | -$75.3K | ﹤0.01% | 2842 |
|
2017
Q2 | $155K | Sell |
99,100
-109,138
| -52% | -$171K | ﹤0.01% | 2736 |
|
2017
Q1 | $673K | Buy |
208,238
+166,138
| +395% | +$537K | ﹤0.01% | 2305 |
|
2016
Q4 | $59K | Buy |
+42,100
| New | +$59K | ﹤0.01% | 2958 |
|